Atrial fibrillation (A-Fib) remains the most common cardiac dysrhythmia seen in clinical practice today, estimated to affect about 2 to 3 million Americans. The prevalence by 2050 is projected to be 15.9 million, with greater than half of those suffering being 80 years of age or older. Moreover, A-fib is not only its own risk factor for mortality, but it also has a significant association of morbidity.

To decrease admissions (and Readmissions) for A-Fib, some hospitals have chosen to implement evidenced-based practice guidelines that incorporate rate control with medications, emergent cardioversions, and patient referral to a dedicated A-Fib clinic, thus avoiding unnecessary admission for this condition.

Download this webinar to learn about a unique approach to continue to curb the epidemic.